Corrigendum to "Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom". [Tetrahedron 63 (2007) 5274] (DOI:10.1016/j.tet.2007.03.155);Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9H-purines bearing a nitrobenzenesulfonyl group on the nitrogen atom

Tetrahedron

Volumn 63, Issue 24, 2007, Pages 5274-5286

  Díaz Gavilán, Mónica ^a   Choquesillo Lazarte, Duane ^a   González Pérez, Josefa M ^a   Gallo, Miguel A ^a   Espinosa, Antonio ^a   Campos, Joaquín M ^a  

^a Facultad de Farmacia   (Spain)

Author keywords

Acetals; Benzoxazepines; Medium ring heterocycles; Purines; X ray

Indexed keywords

3 METHOXY 1 [(2) NITROBENZENESULFONYL)] 1,2,3,5 TETRAHYDRO 4,1 BENZOXAZEPINE; 3 METHOXY 1 [(4) NITROBENZENESULFONYL)] 1,2,3,5 TETRAHYDRO 4,1 BENZOXAZEPINE; 6 CHLORO 7 (1,2,3,5 TETRAHYDRO 4,1 BENZOXAZEPIN 3 YL) 7H PURINE; 6 CHLORO 9 (1,2,3,5 TETRAHYDRO 4,1 BENZOXAZEPIN 3 YL) 9H PURINE; 6 CHLOROPURINE; BENZENE DERIVATIVE; CARBAMIC ACID; DIMETHYL SULFOXIDE; FLUOROURACIL; HYDROXYL GROUP; LEWIS ACID; NITROGEN; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SULFONAMIDE; THIOPHENOL; UNCLASSIFIED DRUG; URACIL;

ALKYLATION; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERIZATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SPECTROSCOPY; X RAY DIFFRACTION;

EID: 34247866205     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.06.035     Document Type: Erratum

References (34)

1. Díaz-Gavilán M., Rodríguez-Serrano F., Gómez-Vidal J.A., Marchal J.A., Aránega A., Gallo M.A., Espinosa A., and Campos J.M. Tetrahedron 60 (2004) 11547
2. Díaz-Gavilán M., Gómez-Vidal J.A., Entrena A., Gallo M.A., Espinosa A., and Campos J.M. J. Org. Chem. 71 (2006) 1043
3. Vorbrüggen H., and Ruh-Pohlenz C. Synthesis of Nucleosides. In: Paquette L.A. (Ed). Organic Reactions (New York) Vol. 55 (2000), John Wiley and Sons, New York, NY 1-630
4. Hasan A., and Srivstava P. J. Med. Chem. 35 (1992) 1435
5. Brik A., Wu C.Y., Best M.D., and Wong C.H. Bioorg. Med. Chem. 13 (2005) 4622
6. Yamada K., Sakata S., and Yoshimura Y. J. Org. Chem. 63 (1998) 6891
7. Peterson M.L., and Vince R. J. Med. Chem. 34 (1991) 2787
8. Hocková D., Budesinsky M., Marek R., Marek J., and Holy A. Eur. J. Org. Chem. (1999) 2675
9. 4 and MeCN at rt, while the N-9 alkylated products were obtained with the same purines, but using TMSOTf and refluxing 1,2-dichloroethane as solvent
10. Okumura K., Oine T., Yamada Y., Tomie M., Adachi T., Natura T., Kawazu M., Mizoguchi T., and Inoue I. J. Org. Chem. 36 (1971) 1573
11. Marek R., Brus J., Tousek J., Kovacs L., and Hocková D. Magn. Reson. Chem. 40 (2002) 353
12. Holy A., Dvorakova H., Jindrich J., Masojidkova M., Budesinsky M., Balzarini J., Andrei G., and De Clercq E. J. Med. Chem. 39 (1996) 4073
13. 1 group are numbered with primes (′), while the purine bases are numbered with double primes (″).
14. Saniger E., Campos J.M., Entrena A., Marchal J.A., Suárez I., Aránega A., Choquecillo D., Niclós J., Gallo M.A., and Espinosa A. Tetrahedron 59 (2003) 5457
15. Saniger E., Campos J.M., Entrena A., Marchal J.A., Boulaiz H., Aránega A., Gallo M.A., and Espinosa A. Tetrahedron 59 (2003) 8017
16. 6 have been developed at 303 and 213 K, and prevalence of the 9H tautomer has been found, see:. Seckárová P., Marek R., Malinaková K., Kolehmainen E., Hockova D., Hocek M., and Sklenár V. Tetrahedron Lett. 45 (2004) 6259
17. Boryski J., and Manikowski A. Nucleosides Nucleotides 18 (1999) 1057
18. Isomer's identification has been made from the value of the coupling constant between the olefinic hydrogens in each structure.
19. For examples of E2 syn eliminations of hydrogen atoms α- to protonated purines, see:. Rodgers M.T., Campbell S., Marzluff E.M., and Beauchamp J.L. Int. J. Mass Spectrom. Ion Processes 148 (1995) 1
20. Girgis N.S., Cottam H.B., Larson S.B., and Robins R.K. J. Heterocycl. Chem. 24 (1987) 821
21. Horhota A.T., Szostak J.W., and McLaughlin L.W. Org. Lett. 8 (2006) 5345
22. Koppel H.C., O'Brien D.E., and Robins R.K. J. Org. Chem. 24 (1959) 259
23. Pathak A.K., Pathak V., Seitz L.E., Suling W.J., and Reynolds R.C. J. Med. Chem. 47 (2004) 273
24. Keck Jr. J.H., Simpson R.A., and Wong J.L. J. Org. Chem. 43 (1978) 2587
25. 3 allows the nucleophile attack at the position 6, in DMF, see: Gurvich, V.; Kim, H. Y.; Hodge, R. P.; Harris, C. M.; Harris, T. M. Abstracts of Papers, 218th ACS National Meeting, New Orleans, 1999.
26. Fukuyama T., Jow C.K., and Cheung M. Tetrahedron Lett. 36 (1995) 6373
27. Willker W., Leibfritz D., Kerssebaum R., and Bermel W. Magn. Reson. Chem. 31 (1993) 287
28. Hurd R.E., and John B.K. J. Magn. Reson. 91 (1991) 648
29. Bruker. SMART and SAINT. Area Detector Control and Integration Software (1997), Bruker Analytical X-ray Instruments, Madison, WI
30. Sheldrick G.M. SADABS. Program for Empirical Absorption Correction of Area Detector Data (1997), University of Göttingen, Göttingen, Germany
31. Sheldrick G.M. Acta Crystallogr. A46 (1990) 467
32. Sheldrick G.M. SHELXL-97. Program for the Refinement of Crystal Structures (1997), University of Göttingen, Göttingen, Germany
33. Spek A.L. PLATON. A Multipurpose Crystallographic Tool (2003), Utrecht University, Utrecht
34. Bruker. SHELXTL: Integrated System for the Determination of Crystal Structures (2000), Bruker AXS, Madison, WI